This webcast originally aired as a live webinar sponsored
by AACC and Seattle Children?s Hospital on April 29, 2014. Toxicology testing in
newborns is often an overlooked area of drug screening. However, recognizing the
population-specific challenges of neonate drug screening related to sample type,
analyte and the medico-legal implications of test results can allow laboratories
to work more effectively with healthcare providers. During this program, Dr.
Steven Cotton will address how labs can balance institution resources and tailor
their test offerings to maximize drug screen utility, as well as how to avoid
common pitfalls in this unique area of toxicology testing. At the end of this
activity, participants will be able to explain why neonate toxicology testing is
often overlooked in newborns; identify the common pitfalls labs experience
related to neonate drug testing; and identify the types of hospital resources
that must be balanced when offering neonate testing.